Outcomes of Vesicourethral Anastomotic Stenosis and Bladder Neck Contracture With Direct Visual Internal Urethrotomy With Mitomycin-C After Prostate Cancer Treatment

医学 前列腺切除术 外科 膀胱颈 吻合 放射治疗 前列腺 泌尿科 前列腺癌 挛缩 狭窄 膀胱 癌症 放射科 内科学
作者
Emily Hacker,Avinash Maganty,Maria M. Pere,Paul Rusilko
出处
期刊:Urology [Elsevier]
卷期号:165: 331-335 被引量:6
标识
DOI:10.1016/j.urology.2022.01.041
摘要

To examine the use of Direct Visual Internal Urethrotomy with Mitomycin-C (DVIU-MMC) for bladder neck contracture and vesicourethral anastomotic stenosis in men who have undergone treatment for prostate cancer with radical prostatectomy and/or radiation therapy.Retrospective chart review of patients at a tertiary care center who underwent DVIU-MMC for recurrent bladder neck contracture/vesicourethral anastomotic stenosis between 2012 and 2020. Patients with complete urethral obliteration, prior bladder neck reconstruction, or less than 3 months of follow-up were excluded. Patients were sorted into three groups based on prostate cancer treatment history: radical prostatectomy (RP), RP with subsequent external beam radiation therapy (RP-EBRT), and radiation therapy (RT).Fifty-one patients with a median follow up of 32 months were included. Twenty-nine percent had pre-operative suprapubic tube (SPT), Foley, or required clean intermittent catheterization. Overall success after initial DVIU-MMC was 45%. In all patients with up to four procedures, cumulative overall success was 84%. There was no significant difference in relative success rates between groups. However, the interval to recurrence after initial DVIU-MMC was shortest for RP-EBRT group (P = .018). Three patients required SPT, all were in the RP-EBRT group. There was no statistical difference in recurrence after any number of procedures between patients in radiation (RP-EBRT and RT) and non-radiation (RP) groups.There was no significant difference in success rates between patients who had undergone RP-EBRT, RT, or RP. However, our data suggests that RP-EBRT patients experience poorer outcomes given that their interval to recurrence was more rapid and all patients requiring SPT placement were in this group.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
负责的念波完成签到,获得积分10
1秒前
俏皮的秋天完成签到,获得积分10
1秒前
LLLL发布了新的文献求助10
1秒前
2秒前
2秒前
酷波er应助zl采纳,获得10
2秒前
zhaogl完成签到,获得积分10
2秒前
xxnn发布了新的文献求助10
3秒前
求助NE发布了新的文献求助10
3秒前
3秒前
前交叉还在完成签到,获得积分20
4秒前
4秒前
安怀完成签到,获得积分10
4秒前
青阳发布了新的文献求助10
5秒前
风信子完成签到 ,获得积分10
5秒前
机智ss完成签到,获得积分10
6秒前
苏白发布了新的文献求助10
6秒前
6秒前
完美世界应助艽野采纳,获得10
6秒前
上官若男应助hyfan采纳,获得30
7秒前
无花果应助科研通管家采纳,获得10
7秒前
8秒前
Yet.完成签到,获得积分10
8秒前
CipherSage应助科研通管家采纳,获得10
8秒前
8秒前
英俊的铭应助科研通管家采纳,获得10
8秒前
8秒前
8秒前
科研通AI2S应助科研通管家采纳,获得10
8秒前
科研通AI2S应助奋斗友儿采纳,获得10
8秒前
8秒前
天天快乐应助科研通管家采纳,获得10
8秒前
Cinatolii发布了新的文献求助10
8秒前
8秒前
wo完成签到,获得积分20
8秒前
在水一方应助科研通管家采纳,获得10
8秒前
科目三应助科研通管家采纳,获得10
8秒前
9秒前
小二郎应助科研通管家采纳,获得10
9秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
Foreign Policy of the French Second Empire: A Bibliography 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
XAFS for Everyone 500
Classics in Total Synthesis IV 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3144482
求助须知:如何正确求助?哪些是违规求助? 2796014
关于积分的说明 7817418
捐赠科研通 2452067
什么是DOI,文献DOI怎么找? 1304867
科研通“疑难数据库(出版商)”最低求助积分说明 627330
版权声明 601432